Manning & Napier Group, LLC Organon & Co. Transaction History

Manning & Napier Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$31.66 - $38.9 $660,427 - $811,454	-20,860 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$30.45 - $39.36 $310,163 - $400,920	-10,186 Reduced 32.81%	20,860 $728,000
Q4 2021 Jan 27, 2022	SELL	$28.67 - $37.13 $222,737 - $288,462	-7,769 Reduced 20.02%	31,046 $945,000
Q3 2021 Oct 14, 2021	SELL	$28.63 - $35.64 $838,773 - $1.04 Million	-29,297 Reduced 43.01%	38,815 $1.27 Million
Q2 2021 Jul 19, 2021	BUY	$28.45 - $38.0 $1.94 Million - $2.59 Million	68,112 New	68,112 $2.06 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Group, LLC with notifications on news.